Literature DB >> 9505071

[Immunologic, alloantigen-dependent factors in chronic graft rejection].

C Barth1, J Stachowski, A von Menges, P Lammerding, C A Baldamus.   

Abstract

BACKGROUND: The pathogenesis of chronic renal allograft rejection is still speculative. Amongst other factors immune-mediated graft injury is proposed. Since the allo-antigen is specifically recognized by the variable (V) alpha and beta chains of the T-cell receptor, a restricted T-cell repertoire might support the notion of allo-antigen involvement in chronic rejection.
METHODS: By the means of semiquantitative polymerase chain reaction the V beta families 1-20 were assessed in allograft biopsies with histologically confirmed chronic and acute rejection. At the same time the V beta repertoire was analyzed in PBMC. RESULT: The intragraft V beta repertoire was limited to 1 to 3 dominant V beta families in chronic and acute rejection. The response was highly individual and did not correlate to the type or degree of HLA mismatches. The T-cell repertoire in PBMC was polyclonal and did not reflect the immune response in the graft.
CONCLUSION: The finding of a restricted V beta repertoire in both forms of rejection might indicate an immunological basis not only for acute, but also for ongoing chronic rejection. Tailor-made antibodies against the dominant V beta clones might provide a tool for selective immunosuppression in both entities of rejection targeting only those T cells which were activated by allo-antigens.

Mesh:

Substances:

Year:  1998        PMID: 9505071     DOI: 10.1007/BF03045032

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  28 in total

1.  T cells receptor beta-chain repertoires are nonrandomly selected in responses to HLA-DR1.

Authors:  S L Hand; M D Alter; O J Finn
Journal:  Transplantation       Date:  1996-04-15       Impact factor: 4.939

Review 2.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

3.  Analysis of T cell lines from rejecting renal allografts.

Authors:  B A Yard; M Kooymans-Couthino; T Reterink; P van den Elsen; M E Paape; J A Bruyn; L A van Es; M R Daha; F J van der Woude
Journal:  Kidney Int Suppl       Date:  1993-01       Impact factor: 10.545

Review 4.  Molecular mechanisms of chronic renal allograft rejection.

Authors:  K Lemström; P Koskinen; P Häyry
Journal:  Kidney Int Suppl       Date:  1995-12       Impact factor: 10.545

5.  T-cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis.

Authors:  L Struyk; J T Kurnick; G E Hawes; J M van Laar; R Schipper; J R Oksenberg; L Steinman; R R de Vries; F C Breedveld; P van den Elsen
Journal:  Hum Immunol       Date:  1993-08       Impact factor: 2.850

6.  Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis.

Authors:  J R Oksenberg; M A Panzara; A B Begovich; D Mitchell; H A Erlich; R S Murray; R Shimonkevitz; M Sherritt; J Rothbard; C C Bernard; L Steinman
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

7.  Histopathologic findings associated with a chronic, progressive decline in renal allograft function.

Authors:  B L Kasiske; R S Kalil; H S Lee; K V Rao
Journal:  Kidney Int       Date:  1991-09       Impact factor: 10.612

8.  Functional and molecular characterization of graft-infiltrating T lymphocytes propagated from different biopsies derived from one heart transplant patient.

Authors:  G Datema; L M Vaessen; R C Daane; C C Baan; W Weimar; F H Claas; P J van den Elsen
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

9.  Endothelial activation and chronic allograft rejection.

Authors:  C G Orosz
Journal:  Clin Transplant       Date:  1994-06       Impact factor: 2.863

10.  Contribution of direct and indirect recognition pathways to T cell alloreactivity.

Authors:  Z Liu; Y K Sun; Y P Xi; A Maffei; E Reed; P Harris; N Suciu-Foca
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.